Journal ArticleOPEN ACCESS

Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: A case report

Clinical Case Reports (2016) 4(3) 282-286
DOI: 10.1002/ccr3.506
7Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Tyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph-) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph- cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.

Author supplied keywords

Cite

CITATION STYLE

APA

Jawad, M. D., Go, R. S., Ketterling, R. P., Begna, K. H., Reichard, K. K., & Shi, M. (2016). Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: A case report. Clinical Case Reports, 4(3), 282–286. https://doi.org/10.1002/ccr3.506

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free